O-(叔丁基)-D-苏氨酸甲酯盐酸盐 | 115141-43-0

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 天然氨基酸及其衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: O-(叔丁基)-D-苏氨酸甲酯盐酸盐
• 英文名称: D-Thr-(O-t-Bu)-OMe, HCl
• 英文别名: H-D-Thr(tBu)-OMe.HCl；methyl (2R,3S)-2-amino-3-[(2-methylpropan-2-yl)oxy]butanoate;hydrochloride
• CAS: 115141-43-0
• 化学式: C₉H₁₉NO₃*ClH
• 分子量: 225.716
• InChiKey: SDHKEUUZUMQSAD-UOERWJHTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.11
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  61.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2922509090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: H-D-Thr(tBu)-OMe HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: H-D-Thr(tBu)-OMe HCl
CAS number: 115141-43-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H19NO3.ClH
Molecular weight: 225.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  O-(叔丁基)-D-苏氨酸甲酯盐酸盐 在 碘苯二乙酸 、 palladium diacetate 、 magnesium sulfate 、 1-羟基苯并三唑 、 溶剂黄146 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 、 sodium hydroxide 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 甲苯 为溶剂， 反应 25.67h， 生成 (S)-1-((2S,3S)-4-(tert-butoxy)-3-((tert-butoxycarbonyl)((S)-3,4-di-tert-butoxy-4-oxobutyl)amino)-2-hydroxy-4-oxobutyl)azetidine-2-carboxylic acid
  参考文献：
  名称：

  植物铁素天然产物的统一方法。

  摘要：

  这项工作报告了 mugineic 酸和 avenic 酸家族（植物铁载体）的八种天然产物的简明全合成。三聚体产品的创新“从东到西”组装产生了高度的差异，使得最终产品的形成只需 10 或 11 个步骤，每个步骤所需的整体合成工作量最少。手性池起始材料（l-苹果酸、苏氨酸）用于外部构建单元，而中间构建单元通过非对映和对映选择性方法获得。这项工作的一个亮点在于直接制备差向异构羟基氮杂环丁烷氨基酸，它们本身就是有用的组成部分，从而能够首次合成 3''-羟基麦根酸和 3''-羟基-2'-脱氧麦根酸。

  DOI：

  10.1002/chem.202004004

文献信息

• Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for .delta. opioid receptors
  作者：G. Gacel、V. Dauge、P. Breuze、P. Delay-Goyet、B. P. Roques

  DOI：10.1021/jm00118a005

  日期：1988.10

  previously reported delta specific agonists DSLET (Tyr-D-Ser-Gly-Phe-Leu-Thr) and DTLET (Tyr-D-Thr-Gly-Phe-Leu-Thr). In binding studies based on displacement of mu and delta opioid receptor selective radiolabeled ligands from rat brain membranes, the two constrained hexapeptides, Tyr-D-Ser(O-t-Bu)-Gly-Phe-Leu-Thr (1, DSTBULET) (KI(mu) = 374 nM, Kr(delta) = 6.14 nM, KI(delta)/KI(mu) = 0.016) and in particular

  设计了一系列线性构象受限的阿片样物质肽，以试图开发出对δ阿片样物质受体的高度选择性和有效的激动剂。这些脑啡肽类似物对应于通式Tyr-DX（OY）-Gly-Phe-Leu-Thr（OZ）是通过掺入大量残基获得的（X = Ser或Thr; Y =叔丁基或苄基; Z =叔-丁基）加入先前报道的δ特异性激动剂DSLET（Tyr-D-Ser-Gly-Phe-Leu-Thr）和DTLET（Tyr-D-Thr-Gly-Phe-Leu-Thr）的序列中。在基于从大鼠脑膜置换mu和delta类阿片受体选择性放射性标记配体的结合研究中，两个受约束的六肽Tyr-D-Ser（Ot-Bu）-Gly-Phe-Leu-Thr（1，DSTBULET）（KI （μ）= 374 nM，Krδ= 6.14 nM，KIδ/KIμ= 0.016），尤其是Tyr-D-Ser（Ot-Bu）-Gly-Phe-Leu-Thr（Ot -Bu）（7，BUBU）（KI（μ）=
• Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof
  申请人：Evans Karen

  公开号：US20070249670A1

  公开（公告）日：2007-10-25

  The invention relates to glycogen phosphorylase inhibitor compounds, pharmaceutical compositions of these compounds, methods of treatment using the pharmaceutical compositions to treat diabetes, conditions associated with diabetes, and/or tissue ischemia, including myocardial ischemia, and processes for making the compounds.

  本发明涉及糖原磷酸化酶抑制剂化合物、这些化合物的药物组合物、使用这些药物组合物治疗糖尿病、与糖尿病相关的疾病和/或组织缺血，包括心肌缺血的方法，以及制备这些化合物的过程。
• A Unified Approach to Phytosiderophore Natural Products
  作者：Nicolas Kratena、Tobias Gökler、Lara Maltrovsky、Eva Oburger、Christian Stanetty

  DOI：10.1002/chem.202004004

  日期：2021.1.7

  the concise total synthesis of eight natural products of the mugineic acid and avenic acid families (phytosiderophores). An innovative „east‐to‐west“ assembly of the trimeric products resulted in a high degree of divergence enabling the formation of the final products in just 10 or 11 steps each with a minimum of overall synthetic effort. Chiral pool starting materials (l‐malic acid, threonines) were

  这项工作报告了 mugineic 酸和 avenic 酸家族（植物铁载体）的八种天然产物的简明全合成。三聚体产品的创新“从东到西”组装产生了高度的差异，使得最终产品的形成只需 10 或 11 个步骤，每个步骤所需的整体合成工作量最少。手性池起始材料（l-苹果酸、苏氨酸）用于外部构建单元，而中间构建单元通过非对映和对映选择性方法获得。这项工作的一个亮点在于直接制备差向异构羟基氮杂环丁烷氨基酸，它们本身就是有用的组成部分，从而能够首次合成 3''-羟基麦根酸和 3''-羟基-2'-脱氧麦根酸。